These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 26565897)
1. High rate of vaccine failure after administration of acellular pertussis vaccine pre- and post-liver transplantation in children at a children's hospital in Japan. Ito K; Kasahara M; Saitoh A; Honda H; Miyairi I Transpl Infect Dis; 2016 Feb; 18(1):150-4. PubMed ID: 26565897 [TBL] [Abstract][Full Text] [Related]
2. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination. Smits K; Pottier G; Smet J; Dirix V; Vermeulen F; De Schutter I; Carollo M; Locht C; Ausiello CM; Mascart F Vaccine; 2013 Dec; 32(1):111-8. PubMed ID: 24176499 [TBL] [Abstract][Full Text] [Related]
3. Type-specific efficacy of acellular pertussis vaccine. Aoyama T; Murase Y; Gonda T; Iwata T Am J Dis Child; 1988 Jan; 142(1):40-2. PubMed ID: 2893537 [TBL] [Abstract][Full Text] [Related]
4. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough. Winsnes R; Lønnes T; Møgster B; Berdal BP Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124 [TBL] [Abstract][Full Text] [Related]
5. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704 [TBL] [Abstract][Full Text] [Related]
6. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age. Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247 [TBL] [Abstract][Full Text] [Related]
7. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children. Hallander HO; Ljungman M; Storsaeter J; Gustafsson L APMIS; 2009 Nov; 117(11):797-807. PubMed ID: 19845530 [TBL] [Abstract][Full Text] [Related]
8. Japanese clinical trials with Takeda acellular pertussis vaccine. Kuno-Sakai H; Kimura M; Ozaki K; Isomura S; Kamiya H; Nii R; Kato T; Horiuchi K; Syukuda Y; Fujita I Tokai J Exp Clin Med; 1988; 13 Suppl():15-9. PubMed ID: 2908519 [TBL] [Abstract][Full Text] [Related]
9. Do Pertussis Vaccines Protect Against Bordetella parapertussis? Liko J; Robison SG; Cieslak PR Clin Infect Dis; 2017 Jun; 64(12):1795-1797. PubMed ID: 28369240 [TBL] [Abstract][Full Text] [Related]
10. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content. Hendrikx LH; Berbers GA; Veenhoven RH; Sanders EA; Buisman AM Vaccine; 2009 Nov; 27(47):6530-6. PubMed ID: 19729085 [TBL] [Abstract][Full Text] [Related]
11. Serological correlates of immunity to Bordetella pertussis. Hewlett EL; Halperin SA Vaccine; 1998 Dec; 16(20):1899-900. PubMed ID: 9796040 [No Abstract] [Full Text] [Related]
12. [Efficacy of acellular pertussis vaccines]. Wirsing von König CH; Finger H Immun Infekt; 1995 Aug; 23(4):125-9. PubMed ID: 7558115 [TBL] [Abstract][Full Text] [Related]
13. Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons. Taranger J; Trollfors B; Bergfors E; Knutsson N; Sundh V; Lagergård T; Lind-Brandberg L; Zackrisson G; White J; Cicirello H; Fusco J; Robbins JB Clin Infect Dis; 2001 Oct; 33(7):1004-10. PubMed ID: 11528572 [TBL] [Abstract][Full Text] [Related]
14. Pertussis in the Era of New Strains of Bordetella pertussis. Souder E; Long SS Infect Dis Clin North Am; 2015 Dec; 29(4):699-713. PubMed ID: 26337739 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for acellular and whole-cell pertussis vaccine failure in Senegalese children. Lacombe K; Yam A; Simondon K; Pinchinat S; Simondon F Vaccine; 2004 Dec; 23(5):623-8. PubMed ID: 15542182 [TBL] [Abstract][Full Text] [Related]
17. The control of pertussis--2007 and beyond. Halperin SA N Engl J Med; 2007 Jan; 356(2):110-3. PubMed ID: 17215528 [No Abstract] [Full Text] [Related]
18. Antibody response from whole-cell pertussis vaccine immunized Brazilian children against different strains of Bordetella pertussis. Pereira A; Pietro Pereira AS; Silva CL; de Melo Rocha G; Lebrun I; Sant'Anna OA; Tambourgi DV Am J Trop Med Hyg; 2010 Apr; 82(4):678-82. PubMed ID: 20348518 [TBL] [Abstract][Full Text] [Related]
19. Effect of injection site on reactogenicity and immunogenicity of acellular and whole-cell pertussis component diphtheria-tetanus-pertussis vaccines in infants. Tapiainen T; Cherry JD; Heininger U Vaccine; 2005 Oct; 23(43):5106-12. PubMed ID: 16023771 [TBL] [Abstract][Full Text] [Related]
20. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. Gustafsson L; Hallander HO; Olin P; Reizenstein E; Storsaeter J N Engl J Med; 1996 Feb; 334(6):349-55. PubMed ID: 8538705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]